How is multiplex testing with next-generation sequencing different from other diagnostic tools? Dr. Balazs Halmos, the Director of Thoracic Oncology and Clinical Cancer Genomics at Montefiore Medical Park at Eastchester in the Bronx, New York, discusses how this type of testing can contribute to improved health outcomes and tailored treatment regimens for patients with non-small cell lung cancer, or NSCLC.